CN102462706A - Agaric extract pellet and preparation method thereof - Google Patents
Agaric extract pellet and preparation method thereof Download PDFInfo
- Publication number
- CN102462706A CN102462706A CN 201010549809 CN201010549809A CN102462706A CN 102462706 A CN102462706 A CN 102462706A CN 201010549809 CN201010549809 CN 201010549809 CN 201010549809 A CN201010549809 A CN 201010549809A CN 102462706 A CN102462706 A CN 102462706A
- Authority
- CN
- China
- Prior art keywords
- auricularia extract
- excipient
- pellet preparations
- binding agent
- auricularia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides an agaric extract pellet preparation which is prepared from an agaric extract and pharmaceutic adjuvants and is characterized in that the pharmaceutic adjuvants comprise an excipient and a binding agent; and the pellet preparation comprises 15-70wt% of the agaric extract, 25-84wt% of the excipient and 1-5wt% of the binding agent. The pellet preparation can be prepared into a sustained-release preparation or an enteric preparation according to requirements. Pharmacology experiments show that the pellet provided by the invention has the effects of improving the immunity, resisting cancers and the like.
Description
Technical field
The present invention relates to the medicine food technical field, be specifically related to micropill that a kind of Auricularia extract processes and preparation method thereof.
Background technology
Auricularia extract uses the high-quality Auricularia to be raw material, forms through the technology fermented extracted.Auricularia extract is rich in abundant Auricularia polysaccharide, is made up of monosaccharide such as L-fucose, L-arabinose, D-xylose, D-mannose, D-glucose and glucuronic acids.Auricularia property is sweet, flat, nontoxic.Can fill blood cooling blood for hemostasis, lung moistening stomach reinforcing, dryness moistening and intestine benefiting, relaxing muscles and tendons and activating QI and blood in the collateral, the strong will of making light of one's life by commiting suicide.Diseases such as treatment deficiency of both QI and blood, cough due to deficiency of the lung, puerperal asthenia.Auricularia contains human body necessary eight seed amino acids and vitamin, has higher nutritive value and certain medical value.Contain abundant colloid in the Auricularia, digestion is had good clear and rich effect, have esophagus clearly, intestinal lavage, lung moistening reduces blood clotting, relaxes coronary atherosclerosis, reduces the effect of thrombosis.Polysaccharide body material in the Auricularia has certain effect to the prevention human tumor, also is the indispensable health food of workman under the high dust work condition in textile industry, barbering and mine.
At present, receive consumers in general's approval deeply about the product of Auricularia extract, these products are common tablet and capsule basically, but above-mentioned dosage form exists disintegration time long; A certain site disintegrate in vivo has certain zest to gastric mucosa; Shortcomings such as bioavailability is low.Based on the problems referred to above, we will develop rapidly that the micropill technology is incorporated into field of food at field of medicaments, these article processed discharge micro-pill type product controlled and that bioavailability is high in vivo, to satisfy consumers in general's demand better.
Generally to add pharmaceutic adjuvants such as excipient, binding agent, porogen, disintegrating agent, plasticizer [" design and development of sustained-release and controlled release preparation " Yan Yaodong etc. in the preparation process of pellet preparations; Chinese Medicine science and technology publishing house; 2006,257-258], in the research process of micropill; Need carry out deep research to formulation preparation, just can prepare qualified micropill product.
Summary of the invention
For these reasons, we carry out deep analysis to Auricularia extract physics and chemical property, are index with the dissolution; Test through science; Confirm that pharmaceutic adjuvant is excipient and binding agent, and excipient and binding agent are carried out confirming of weight percentage: " pharmaceutic adjuvant is excipient and binding agent, and wherein the Auricularia extract weight percentage is 15%-70% in the pellet preparations; the excipient weight percentage is 25%-84%, and the percentage composition of binding agent is 1%-5% "; Through this complete technical scheme, those skilled in the art just can prepare satisfactory pellet preparations according to the method for preparing of the micropill of prior art; Above-mentioned pellet preparations can be prepared into satisfactory slow releasing preparation or enteric coated preparation, help user's compliance.We carry out deep research to Auricularia extract pellet preparations method for preparing on the basis of existing technology, and unexpected the discovery carried out sufficient pulverizing with Auricularia extract and excipient; Be that micronization is pulverized, Auricularia extract has been distributed in the excipient well, make particle diameter reach micro powder grade; Material with such is processed micropill, and in the process that discharges in vivo, main constituent can discharge rapidly along with the dissolving of excipient; And these article are made up of the little micropill unit of hundreds of grain, disperse area big in vivo, and the organ contacted specific surface area is also big with absorbing; Admittedly onset was rapid after these article of making were taken, bioavailability is high.
The objective of the invention is provides a kind of novel formulation of Auricularia extract---pellet preparations in order to overcome the problems of the prior art.
Another object of the present invention is to provide a kind of method for preparing of Auricularia extract pellet preparations, this method is simple, convenient, easy operating.
Auricularia extract of the present invention prepares according to existing literature method or patented method.
The objective of the invention is to realize through following technical scheme:
A kind of Auricularia extract pellet preparations; It is to be prepared from Auricularia extract and pharmaceutic adjuvant; It is characterized in that pharmaceutic adjuvant is excipient and binding agent; Wherein the Auricularia extract weight percentage is 15-70% in the pellet preparations, and the excipient weight percentage is 25-84%, and the percentage composition of binding agent is 1-5%.
The slow release formulation of above-mentioned Auricularia extract pellet preparations preparation.
Or the enteric dosage form of above-mentioned Auricularia extract pellet preparations preparation.
Wherein said excipient is one or more the mixture that is selected from sucrose, dextrin, starch, microcrystalline Cellulose, lactose, methylcellulose, sodium carboxymethyl cellulose, polyvinylpyrrolidone, ethyl cellulose, acrylic resin, hydroxypropyl emthylcellulose and the gelatin.
Wherein said binding agent is one or more the mixture in polyvinylpyrrolidone, cellulose family, resinae, saccharide, the animal acid.
Pellet preparations of the present invention can be according to technique scheme, prepares with the method for preparing of prior art pellet preparations, also can prepare according to following method:
A kind of method for preparing of Auricularia extract pellet preparations the steps include:
(1) gets Auricularia extract, add excipient, be crushed to micronized rank, mixing;
(2) in the solution in binding agent is water-soluble, dehydrated alcohol or the aquiferous ethanol;
(3) adopt the micropill forming technique to process micropill.
Wherein said micropill forming technique comprises agitation procedure, method of extruding and kneading to pellets or the centrifugal fluidized granulation method of being selected from.
In the conventional art; The degree of grinding of medical material or extract is coarse powder (in take, particle diameter 850um ± 70um, cross 24 mesh sieves), middle powder (in take, particle diameter 250um ± 9.9um, cross 65 mesh sieves), fine powder (wound usefulness, particle diameter 150um ± 6.6um, cross 100 mesh sieves), fine powder (eye dripping usefulness, particle diameter 125um ± 5.8um, 120 mesh sieves) and impalpable powder (particle diameter 75um ± 4.1um, 200 mesh sieves); The present invention then adopts micronization technology that Auricularia extract is ground into micropowder; Its mean diameter is generally less than 10um, mainly is distributed in 1～20um.Method of micronization can adopt method of the prior art: physical pulverization method, for example mechanical impact crusher, jet mill, ball mill, vibromill, stirring mill, Raymond mill, high-pressure micronizer machine etc.; The physical chemistry synthetic method comprises spray drying, original position micronization and supercritical fluid technology etc.Compare with traditional crushing technology, the main advantage of this technology is: increase the effective ingredient absorbance, improve bioavailability.The dissolution rate of effective ingredient is directly proportional with its specific grain surface is long-pending, and specific surface area and particle diameter are inversely proportional to.Therefore, the particle diameter of effective ingredient is thin more, and then its specific surface area is big more, helps the stripping of effective ingredient more.According to research, the intestines and stomach is about 15um to the optimal absorption granularity of material grains, and the granule of micron composition has just reached this optimal absorption fineness level; Because the micron order effective ingredient obviously increases at the gastrointestinal dissolubility, thereby increases its bioavailability, has accelerated its onset time.
Micropill forming technique among the present invention can adopt any micropill forming technique of the prior art, and these technology include but not limited to: agitation procedure, method of extruding and kneading to pellets or centrifugal fluidized granulation method etc.
Beneficial effect of the present invention is:
(1) in the prior art, do not have Auricularia extract to be prepared into the technology of pellet preparations, we are through carrying out deep analysis to Auricularia extract physics and chemical property; With the dissolution is index; Through the test of science, confirm that pharmaceutic adjuvant is excipient and binding agent, and do not have other pharmaceutic adjuvant; And excipient and binding agent are carried out confirming of weight percentage: " pharmaceutic adjuvant is excipient and binding agent; wherein the Auricularia extract weight percentage is 15-70% in the pellet preparations, and the excipient weight percentage is 25-84%, and the percentage composition of binding agent is 1-5% "; Through this complete technical scheme, those skilled in the art just can prepare satisfactory pellet preparations according to the method for preparing of the micropill of prior art; Above-mentioned pellet preparations can be prepared into satisfactory slow releasing preparation or enteric coated preparation, help user's compliance.Micropill of the present invention and prior art Auricularia extract compared with techniques, supplementary product consumption is few, and steady quality has curative effect repeatability preferably, and adverse reaction rate is low; This product micropill increases at the area that absorbs the organ surface distributed, bioavailability is improved and local excitation is less or eliminate, and selects for consumers in general provide more consumption.
(2) we carry out deep research to Auricularia extract pellet preparations method for preparing on the basis of existing technology, and unexpected the discovery carried out sufficient pulverizing with Auricularia extract and excipient; Be that micronization is pulverized, Auricularia extract has been distributed in the excipient well, make particle diameter reach micro powder grade; Material with such is processed micropill, and in the process that discharges in vivo, main constituent can discharge rapidly along with the dissolving of excipient; And these article are made up of the little micropill unit of hundreds of grain, disperse area big in vivo, and the organ contacted specific surface area is also big with absorbing; Admittedly onset was rapid after these article of making were taken, bioavailability is high.
One, dissolution contrast experiment:
The micropill that micropill of the present invention can be processed rapid release or discharge at a slow speed through different prescriptions as required belongs to multiple agent type, can be made up of the micropill of different drug release rates.Also can pass through packaging technique, micropill processed positioned releasing micropills such as stomach dissolution type, enteric solubility.This micropill can encapsulatedly be processed capsule, or tabletting processes tablet, or makes other various packaged forms.We have carried out release in vitro contrast test (experimental technique is according to Pharmacopoeia of People's Republic of China version dissolution in 2010 check and analysis method) with these article and commercially available tablet and conventional capsule agent, and the result is following:
The conventional capsule agent (the Jilin manufacturer production, lot number: 20090907) 30 minutes dissolution rates are 56% in gastric juice;
Tablet (Liaoning manufacturer production, lot number: 20100104) 30 minutes dissolution rates are 63% in gastric juice;
And these article 30 minutes dissolution rates in gastric juice promptly reach 90%.
Simultaneously, we can also through different coating materials, make product become the product of different sizes such as slow release, controlled release, enteric through micropill being carried out the technology of coating.
Therefore after we process slow-release micro-pill with these article, have 12 hours slow-release function, can effectively control the burst size of Auricularia saponin, safety, effectiveness are better; Slow-release micro-pill can make blood drug level reach curative effect concentration rapidly, and keeps steady, long valid density, and blood concentration fluctuation is little; These article have reduced the accumulated dose of taking than common dosage form simultaneously, have reduced the number of times of taking of consumer.We find that through the release in vitro simulation test its release profiles is obvious with these article, and when 2h, the release degree is more than 30%; During 5h, the release degree is more than 55%; During 8h, the release degree is more than 75%; During 12h, the release degree is more than 90%.
Have the consumer of stomach illness for some, for fear of the influence of product to stomach, these article are absorbed by the body better, we can also process enteric coated preparation with these article, promptly through micropill is carried out enteric coated technology, make product reach the purpose of enteric.We carry out the release in vitro simulation test with this enteric coated micropill and find; The micropill stripping that 2 hours have no in simulated gastric fluid; Outward appearance also has no variation, and when we were put into its taking-up in the simulated intestinal fluid dissolution test, its 30 minutes release degree had just reached more than 85%.
Two, pellet preparations research process:
Get Auricularia extract, according to method [" design and development of sustained-release and controlled release preparation " Yan Yaodong etc., the Chinese Medicine science and technology publishing house of existing document micropill preparation; 2006; 257-258] prepare, can not prepare qualified pellet preparations, therefore; We further study, and experimentize through following experimental technique:
1, the Auricularia extract weight percentage is 15% in the pellet preparations, and the excipient weight percentage is 84%, and the percentage composition of binding agent is 1%.
2, the Auricularia extract weight percentage is 70% in the pellet preparations, and the excipient weight percentage is 25%, and the percentage composition of binding agent is 5%.
3, the Auricularia extract weight percentage is 65% in the pellet preparations, and the excipient weight percentage is 32%, and the percentage composition of binding agent is 3%.
4, the Auricularia extract weight percentage is 20% in the pellet preparations, and the excipient weight percentage is 76%, and the percentage composition of binding agent is 4%.
5, the Auricularia extract weight percentage is 40% in the pellet preparations, and the excipient weight percentage is 58%, and the percentage composition of binding agent is 2%.
Get the micropill of above-mentioned different experiments scheme,, detect according to the Pharmacopoeia of the People's Republic of China (version in 2010) appendix dissolution detection method.
Experimental result: the micropill of above-mentioned different schemes reaches more than 85% at 30 minutes dissolution, proves absolutely that the pellet preparations that the present invention prepares has scientific meaning.
Three, preparation embodiment:
Embodiment 1
A kind of Auricularia extract pellet preparations, pharmaceutic adjuvant are excipient and binding agent, and wherein the Auricularia extract weight percentage is 15% in the pellet preparations, and the excipient weight percentage is 84%, and the percentage composition of binding agent is 1%, prepares qualified pellet preparations.
Embodiment 2
A kind of Auricularia extract pellet preparations, pharmaceutic adjuvant are excipient and binding agent, and wherein the Auricularia extract weight percentage is 70% in the pellet preparations, and the excipient weight percentage is 25%, and the percentage composition of binding agent is 5%.
Embodiment 3
A kind of Auricularia extract pellet preparations, pharmaceutic adjuvant are excipient and binding agent, and wherein the Auricularia extract weight percentage is 65% in the pellet preparations, and the excipient weight percentage is 32.5%, and the percentage composition of binding agent is 2.5%.
Embodiment 4
A kind of Auricularia extract pellet preparations, pharmaceutic adjuvant are excipient and binding agent, and wherein the Auricularia extract weight percentage is 40% in the pellet preparations, and the excipient weight percentage is 57%, and the percentage composition of binding agent is 3%.
Embodiment 5
A kind of Auricularia extract pellet preparations, pharmaceutic adjuvant are excipient and binding agent, and wherein the Auricularia extract weight percentage is 20% in the pellet preparations, and the excipient weight percentage is 76%, and the percentage composition of binding agent is 4%.
Pellet preparations among the foregoing description 1-5 can be prepared into slow releasing preparation or enteric coated preparation according to demands of different.
The pellet preparations binding agent among the foregoing description 1-5 and the selection of excipient are selected to get final product according to the conventional adjuvant of pharmaceutics pellet preparations.
The method for preparing of micropill gets final product according to the method for preparing of existing document micropill among the foregoing description 1-5.
Embodiment 6
Get the raw material for standby of following prescription: Auricularia extract 15 grams (15%), microcrystalline Cellulose 84 grams (84%), hydroxypropyl emthylcellulose 1 gram (1%);
Embodiment 7
Get the raw material for standby of following prescription: Auricularia extract 70 grams (70%), sucrose, dextrin, starch, Celluloasun Microcrystallisatum, lactose and methylcellulose be totally 25 grams (25%), polyvinylpyrrolidone 5 grams (5%);
Embodiment 8
Get the raw material for standby of following prescription: Auricularia extract 65 grams (65%), sucrose 32 grams (32%), cellulose family, resinae and saccharide be totally 3 grams (3%);
Embodiment 9
Get the raw material for standby of following prescription: Auricularia extract 19 grams (19%), sodium carboxymethyl cellulose, ethyl cellulose, acrylic resin, hydroxypropyl emthylcellulose and gelatin be totally 81 grams (81%), resinae 2 grams (2%);
Embodiment 10
Get the raw material for standby of following prescription: Auricularia extract 29 grams (29%), starch is totally 67 grams (67%), and cellulose family, resinae and saccharide be totally 4 grams (4%);
Embodiment 11
Get the raw material for standby of following prescription: Auricularia extract 37g (37%), sucrose 61g (61%), polyvinylpyrrolidone 2g (2%);
Embodiment 12
Get the raw material for standby of following prescription: Auricularia extract 62g (62%), starch 34g (34%), polyvinylpyrrolidone 4g (4%)
The foregoing description 1-12 can also can prepare according to following method according to the art methods preparation:
Embodiment 13
(1) Auricularia extract of getting above-mentioned formula ratio adds excipient, is crushed to micronization rank, mixing with ball mill;
(2) binding agent is dissolved in 75% alcoholic solution;
(3) adopt method of extruding and kneading to pellets to process micropill.
Embodiment 14
(1) Auricularia extract of getting above-mentioned formula ratio adds excipient, is crushed to micronization rank, mixing with ball mill;
(2) binding agent is soluble in water;
(3) adopt agitation procedure to process micropill.
Embodiment 15
(1) Auricularia extract of getting above-mentioned formula ratio adds excipient, is crushed to micronization rank, mixing with ball mill;
(2) binding agent is dissolved in the dehydrated alcohol;
(3) adopt the centrifugal fluidized granulation method to process micropill.
Annotate: the present invention's concrete technical scheme required for protection is not limited to the concrete combination of the expressed technical scheme of the foregoing description.
Claims (7)
1. Auricularia extract pellet preparations; It is to be prepared from Auricularia extract and pharmaceutic adjuvant; It is characterized in that pharmaceutic adjuvant is excipient and binding agent; Wherein the Auricularia extract weight percentage is 15-70% in the pellet preparations, and the excipient weight percentage is 25-84%, and the percentage composition of binding agent is 1-5%.
2. the slow release formulation of Auricularia extract pellet preparations preparation according to claim 1.
3. the enteric dosage form of a kind of Auricularia extract pellet preparations preparation according to claim 1.
4. according to described a kind of Auricularia extract pellet preparations of claim 1, wherein said excipient is one or more the mixture that is selected from sucrose, dextrin, starch, Celluloasun Microcrystallisatum, lactose, methylcellulose, sodium carboxymethyl cellulose, polyvinylpyrrolidone, ethyl cellulose, acrylic resin, hydroxypropyl emthylcellulose and the gelatin.
5. a kind of Auricularia extract pellet preparations according to claim 1, wherein said binding agent are one or more the mixture in polyvinylpyrrolidone, cellulose family, resinae, saccharide, the animal acid.
6. according to the method for preparing of each described a kind of Auricularia extract pellet preparations of claim 1-5, the steps include:
(1) gets Auricularia extract, add excipient, be crushed to micronized rank, mixing;
(2) in the solution in binding agent is water-soluble, dehydrated alcohol or the aquiferous ethanol;
(3) adopt the micropill forming technique to process micropill.
7. method for preparing according to claim 6, wherein said micropill forming technique comprise agitation procedure, method of extruding and kneading to pellets or the centrifugal fluidized granulation method of being selected from.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010549809 CN102462706A (en) | 2010-11-19 | 2010-11-19 | Agaric extract pellet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010549809 CN102462706A (en) | 2010-11-19 | 2010-11-19 | Agaric extract pellet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102462706A true CN102462706A (en) | 2012-05-23 |
Family
ID=46067014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010549809 Pending CN102462706A (en) | 2010-11-19 | 2010-11-19 | Agaric extract pellet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102462706A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103039955A (en) * | 2012-12-28 | 2013-04-17 | 杨石 | Health food with function of boosting immunity |
-
2010
- 2010-11-19 CN CN 201010549809 patent/CN102462706A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103039955A (en) * | 2012-12-28 | 2013-04-17 | 杨石 | Health food with function of boosting immunity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703479A (en) | Resveratrol pellet and preparation method thereof | |
| CN101703540A (en) | Celeryseed extract pellets and preparation method thereof | |
| CN102462715A (en) | Red ginseng extract pellet and preparation method thereof | |
| CN102462722A (en) | Honeysuckle extract pellet and preparation method thereof | |
| CN102462706A (en) | Agaric extract pellet and preparation method thereof | |
| CN101444489A (en) | Astragalus polyose pellet and preparation method thereof | |
| CN101703478A (en) | Zinc gluconate pellets and preparation method thereof | |
| CN101214322A (en) | Grape seed extract micropills and preparation thereof | |
| CN102462717A (en) | American ginseng extract pellet and preparation method thereof | |
| CN101444558A (en) | Desertliving cistanche herb extract pellet and preparation method thereof | |
| CN102462721A (en) | Dangshen extract pellet and preparation method thereof | |
| CN101703532A (en) | Ganoderan polysaccharide pellet and preparation method thereof | |
| CN103845293A (en) | Lutein pellet and preparation method thereof | |
| CN101444487A (en) | Vitamin E micropill and preparation method thereof | |
| CN101214236A (en) | Soybean isoflavone micropills and preparation thereof | |
| CN102462705A (en) | Tremella extract pellet and preparation method thereof | |
| CN101219126A (en) | Beta-carotene pellet and method for preparing the same | |
| CN101219123A (en) | Tea polyphenol pellet and method for preparing the same | |
| CN102462744A (en) | Cortex moutan extract pellet and preparation method thereof | |
| CN101444547A (en) | Sea buckthorn extract pellet and preparation method thereof | |
| CN101214231A (en) | Lycopene micropills and preparation thereof | |
| CN102462707A (en) | Poria extract pellet and preparation method thereof | |
| CN101703476A (en) | Zeaxanthin pellets and preparation method thereof | |
| CN102462704A (en) | Shitake mushroom extract pellet and preparation method thereof | |
| CN101703529A (en) | Cordyceps mycelia polysaccharide pellet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120523 |